Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Chronic Obstructive Pulmonary Disease (COPD) and Osteoporosis
This clinical trial update notes the completion of a study on chronic obstructive pulmonary disease and osteoporosis (NCT01067248). The spon…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD [NA]
Completed clinical trial evaluating the efficacy of inhaled bronchodilators in patients with Chronic Obstructive Pulmonary Disease using ven…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: An Evaluation of Web Based Pulmonary Rehabilitation [Phase 1, Phase 2]
This update documents the completion of Phase 1 and Phase 2 evaluations of a web-based pulmonary rehabilitation program for chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD [Phase 4]
Phase 4 clinical trial evaluating the efficacy of nebulized Pulmicort Respules (budesonide) in patients with primary lung cancer and COPD.
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2 [Phase 4]
A Phase 4 trial evaluating early initiation of tiotropium after hospitalization for an acute COPD exacerbation; results posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial update characterizing 24-hour lung function profiles of the inhaled tiotropium + olodaterol fixed-dose combination in chronic …
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers [Phase 2]
A Phase 2 study evaluated the effects on lung function and ECG of a tiotropium plus olodaterol combination in COPD, comparing administration…
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing a fixed-dose combination of tiotropium and olodaterol versus separate tiotropium and olodaterol in COPD was complete…
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing a fixed-dose combination of tiotropium and olodaterol against separate tiotropium and olodaterol in chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation [Phase 3]
A 12-week, multicenter, randomized, double-blind, placebo- and active-controlled Phase 3 trial evaluating indacaterol maleate combined with …
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD [Phase 2]
Phase 2 trial evaluating XEN-D0501 for reducing cough frequency in Chronic Obstructive Pulmonary Disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial to determine the optimal free-dose combination of tiotropium bromide and BI 1744 CL for chronic obstructive pulmonary diseas…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD. [Phase 1]
Phase 1 pharmacokinetic study in Japanese patients with chronic obstructive pulmonary disease assessing the tiotropium + olodaterol fixed-do…
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Japan Long-term Safety for Tiotropium Plus Olodaterol [Phase 3]
This clinical trial update reports long-term safety results from a Phase 3 study of the tiotropium plus olodaterol combination for chronic o…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD [Phase 3]
Phase 3 trial update reporting results from a 24-week arterial stiffness study of the inhaled corticosteroid/long-acting beta-agonist combin…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study [Phase 4]
A Phase 4 clinical trial update on the SANOB study investigating nitric oxide concentration in patients with chronic obstructive pulmonary d…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1 [Phase 4]
Phase 4 trial assessing early initiation of tiotropium in patients recovering from acute COPD exacerbation hospitalization; completed with r…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily [Phase 4]
Phase 4 study evaluating safety of roflumilast when given once daily on alternate days for two weeks compared with the standard daily dose i…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Correction of Exercise-induced Desaturation by Acute Oxygen Supply and Exercise Responses in COPD
This entry reports the completion of a clinical trial evaluating whether acute oxygen supply during exercise can correct exercise-induced de…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: The Effect on Depressive Symptoms in ECF Residents With COPD [Phase 4]
Phase 4 clinical trial update assessing the effect on depressive symptoms in residents with chronic obstructive pulmonary disease; results p…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD [Phase 1]
A Phase 1 trial evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat dosing with RV1729 for 28 days in patien…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Sit-to-stand and Peripheral Muscle Strength in COPD [NA]
Completion of a Maugeri Foundation clinical trial evaluating sit-to-stand performance and peripheral muscle strength in people with chronic …
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Telemonitoring of Patients With COPD in Carinthia [NA]
Clinical trial update on telemonitoring for patients with Chronic Obstructive Pulmonary Disease in Carinthia; the study completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease [Phase 3]
A Phase 3 trial evaluating natriuretic peptides for acutely decompensated heart failure in patients with obstructive airway disease has been…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069 [Phase 1]
A Phase 1 study assessing safety, tolerability, and effects of multiple dosing with AZD 4721 and AZD 5069 in COPD has completed.